Americans want big pharma reform. Candidates should deliver
Having spent 12 years on Capitol Hill, I know just how rare it is to find an issue with real bipartisan consensus. That’s why when a new national survey shows 94% of voters blame pharmaceutical companies for the high cost of healthcare, it demands our serious attention. The American people are speaking with one voice, and every candidate running in the 2026 midterm elections should be listening.
TL;DR
- 94% of voters blame pharmaceutical companies for high healthcare costs, with 89% demanding drug pricing reform.
- Voters support policies including international price matching (87%), patent reform for generics (81%), and changes to direct-to-consumer advertising (88%).
- Most Favored Nation (MFN) pricing, ensuring Americans pay no more than citizens in comparable nations, has 75% voter support, including 91% of Republicans.
- 77% of voters are more likely to support candidates who challenge the pharmaceutical industry.
- Healthcare affordability is identified as the defining domestic issue for the 2026 election cycle.